3Palmer AJ,Valentine WJ,Chen R,et al.A health economic analysis of screening and optimal treatment of nephropathy in patients with type2diabetes and hypertension in the USA[J].Nephrology Dialysis Transplantation[J].2013,15(l):192.
4Balakumar P5Arora MK,Reddy J,et al.Pathophysiology of dia- bet-ic nephropathy:involvement of multifaceted signalling mechanism[J]Journal of Cardiovascular Pharmacology,2013,10(4):612-613.
5L.Annemans L9Demarteau N,Hu.SAn Asian regional analy- sis of the cost-effectiveness of early irbesartan treatment versus conventional antihypertensive,late amlodipine,and late irbesartan treatments in patients with type 2 diabetes,hypertension,and nephropathy[J].Value in Health,2014,15(7):794-795.
6Martinez Castelao A.Advances in diabetes mellitus,diabetic nephropathy,metabolic syndrome and cardio-vascular-renal risk[J].Nephrologie,2012,8(5):338.
